POINT BIOPHARMA
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.
POINT BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.pointbiopharma.com
Total Employee:
101+
Status:
Active
Contact:
(317) 543-9957
Total Funding:
310 M USD
Technology used in webpage:
WordPress Wordpress Plugins COVID-19 Jetpack Site Accelerator Jetpack YouTube Privacy Enchanced Cookie Notice Astra Theme Hu-manity.co WordPress.com Hosting
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Mondias Natural Products
Mondias Natural Products specializes in the commercialization and development of evidence.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Sunstone Therapies
Sunstone Therapies focuses on the research and commercial delivery of psychedelic therapies for cancer patients.
Current Advisors List
Board_member
2021-06-01
Current Employees Featured
Robin Hallett Vice President, Discovery & Translational Sciences @ Point Biopharma
Vice President, Discovery & Translational Sciences
2021-12-01
Sherin Al-Safadi VP Medical Affairs @ Point Biopharma
VP Medical Affairs
2021-12-01
Bill Demers Chief Financial Officer @ Point Biopharma
Chief Financial Officer
Chris Horvath EVP, Commercial @ Point Biopharma
EVP, Commercial
2022-06-01
Dr. Neil Fleshner Chief Medical Officer @ Point Biopharma
Chief Medical Officer
Justyna Kelly Chief Operating Officer @ Point Biopharma
Chief Operating Officer
2021-12-01
Joe McCann Founder, Chief Executive Officer @ Point Biopharma
Founder, Chief Executive Officer
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Point Biopharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - Point Biopharma
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Point Biopharma
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Point Biopharma
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Point Biopharma
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Point Biopharma
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Point Biopharma
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Point Biopharma
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Post-IPO Equity - Point Biopharma
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Point Biopharma
Key Employee Changes
Official Site Inspections
http://www.pointbiopharma.com
- Host name: a4972715dfa2f21c3.awsglobalaccelerator.com
- IP address: 99.83.188.150
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Point Biopharma"
Point Biopharma
Founded in late 2019, POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment …See details»
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company Biotechnology Indianapolis, Indiana 21,154 followersSee details»
POINT Biopharma - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.pointbiopharma.com. …See details»
Point Biopharma - Crunchbase Company Profile & Funding
Point Biopharma may be growing as evidenced by a significant $1.4 billion takeover bid from Eli Lilly, which indicates a strong valuation and interest from a major pharmaceutical company.See details»
POINT Biopharma - Overview, News & Similar companies
Dec 5, 2023 Who is POINT Biopharma. POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and …See details»
Lilly Completes Acquisition of POINT Biopharma
INDIANAPOLIS, Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. …See details»
POINT Biopharma Company Profile | Management and Employees …
Smith@pointbiopharma.com: POINT Biopharma Top Competitors. Company Employees Revenue Top technologies; Zymeworks. 275: $50.5 M: Precision NanoSystems. 74: $22 M: Phoenix …See details»
POINT Biopharma - Leadership Team | The Org
Comprising key executives such as the CEO, CFO, and Chief Medical Officer, the team collaborates to ensure robust clinical development, financial sustainability, and innovation in …See details»
Point Biopharma Corp Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Point Biopharma Corp of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
POINT Biopharma - 2025 Company Profile - Tracxn
5 days ago Email ID: *****@pointbiopharma.com; Phone Number: +1 ***** Key Metrics. Total Funding. $20M in 1 round. Latest Funding Round. Series A, Aug 04, 2020, $20M. Ranked. 15 …See details»
POINT Biopharma Global - Craft
Dec 26, 2023 POINT Biopharma Global is a radiopharmaceutical company that specializes in cancer treatment solutions. It develops radioligand therapies to diagnose and treat non …See details»
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and …
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, …See details»
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities …
Oct 3, 2023 Learn more about POINT Biopharma Global, Inc. at pointbiopharma.com. About Lilly Lilly unites caring with discovery to create medicines that make life better for people around …See details»
POINT Biopharma - Work in biotech
POINT Biopharma is developing radiopharmaceutical products for cancer treatment. Radioligands are microscopic, cancer-seeking missiles that are actively used to diagnose and treat cancers …See details»
Lilly Completes Acquisition of POINT Biopharma - PR Newswire
INDIANAPOLIS, Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. …See details»
POINT Biopharma adds a COO, Further Strengthens Leadership
Dec 1, 2021 She is also Co-Founder and President of Fondation Amal, a cross-border non-profit organization that celebrates the ability, well-being, and hope of kids with lifelong illness and …See details»
Joe McCann - CEO at POINT Biopharma - The Org
Dr. McCann has overall responsibility for the day-to-day operations of POINT. Prior to taking on this role, Dr. McCann was CEO of Centre for Probe Development and Commercialization …See details»
Series A - Point Biopharma - 2020-08-04 - Crunchbase
Aug 4, 2020 Organization Name . Point Biopharma . Announced Date Aug 4, 2020; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. …See details»
POINT Biopharma Announces New Board Appointments
Dec 9, 2020 Jonathan Ross Goodman, Gerry Hogue and Peggy Gilmour join POINT’s Board of Directors TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc....See details»
POINT Biopharma-POINT Biopharma, Inc.-企业详情-InvestGO数据 …
Dec 31, 2018 查看医药魔方InvestGO®数据库POINT Biopharma的公司信息。POINT Biopharma（POINT Biopharma, Inc.），公司简介：Founded in late 2019, POINT Biopharma …See details»